Skin exposure to isocyanates: Reasons for concern

Environmental Health Perspectives

Volumn 115, Issue 3, 2007, Pages 328-335

  Bello, Dhimiter ^a,b   Herrick, Christina A ^c   Smith, Thomas J ^a   Woskie, Susan R ^b   Streicher, Robert P ^d   Cullen, Mark R ^c   Liu, Youcheng ^c   Redlich, Carrie A ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Asthma; Dermal exposure; Isocyanates; Sensitization; Skin

Indexed keywords

ISOCYANATE; POLYURETHAN;

DATA BASE; ENVIRONMENTAL EXPOSURE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; NONHUMAN; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SKIN ABSORPTION; WORKPLACE;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; ASTHMA; HUMANS; ISOCYANATES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; SKIN; SKIN ABSORPTION;

ANIMALIA;

EID: 34147170104     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9557     Document Type: Review

References (94)

1. Abbas A, Lichtman A, Pober J, eds. 2000. Cellular and Molecular Immunology. 4th ed. Philadelphia:W.B. Saunders Co.
2. ACGIH. 2006. 2006 TLVs® and BEIs®: Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure iIndices. Cincinnati, OH:American Conference of Governmental Industrial Hygienists.
3. Alliance for the Polyurethanes Industry. 2005. Handling the Heat: Polyurethanes and Thermal Degradation, Available: http://www.polyurethane.org/s_api/bin.asp?SID= 3&DID=3848&CID=885&VID=160&DOC=File.PDF [accessed 1 September 2006].
4. Allport D, Gilbert D, Outterside S, eds. 2003. MDI & TDI: Safety, Health and the Environment, West Sussex, UK:John Wiley & Sons Ltd.
5. Alomar A. 1986. Contact dermatitis from a fashion watch. Contact Dermatitis 15:44-45.
6. Bakke J, Noren J, Thorud S, Aasen T. 2006. International Consensus Report on: Isocyanates - Risk Assessment and Management. Available: http://ecb.jrc.it/classlab/2201a17_So_isocyanates.pdf [accessed 2 May 2006].
7. Ban M, Morel G, Langonne I, Huguet N, Pepin E, Binet S. 2006. TDI can induce respiratory allergy with Th2-dominated response in mice. Toxicology 218(1):39-47.
8. Basketter DA, Jefferies D, Safford BJ, Gilmour NJ, Jowsey IR, McFadden J, et al. 2006. The impact of exposure variables on the induction of skin sensitization. Contact Dermatitis 55(3):178-185.
9. Baur X. 2003. Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol 90(5 suppl 2):11-18.
10. Baur X, Marek W, Ammon J, Czuppon AB, Marczynski B, Raulf-Heimsoth M. et al. 1994. Respiratory and other hazards of isocyanates. Int Arch Occup Environ Health 66(3):141-152.
11. Bello D, Ibrahim K, Sparer J, Stowe M, Redlich C, Liu Y. In press. Slow curing of aliphatic polyisocyanate paints in automotive refinishing: a potential source for skin exposure. J Occup Environ Hyg.
12. Bello D, Smith TJ, Woskie SR, Streicher RP, Boeniger MF, Redlich CA, et al. 2006, An FTIR investigation of isocyanate skin absorption using in vitro guinea pig skin. J Environ Monit 8(5):523-529.
13. Bello D, Woskie SR, Streicher RP, Liu Y, Stowe MH, Eisen EA, et al. 2004. Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am J Ind Med 46(5):480-491.
14. Bello D, Woskie SR, Streicher RP, Stowe MH, Sparer J, Redlich CA, et al. 2005. A laboratory investigation of the effectiveness of various skin and surface decontaminants for aliphatic polyisocyanates. J Environ Monit 7(7):716-721.
15. Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, et al. 1993. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 92(3):387-396.
16. Bernstein JA. 1996. Overview of diisocyanate occupational asthma. Toxicology 111(1-3):181-189.
17. Boman A, Maibach HI. 2000. Percutaneous absorption of organic solvents. Int J Occup Environ Health 6(2):93-95.
18. Boukhman MP, Mailbach HI. 2001. Thresholds in contact sensitization: immunologic mechanisms and experimental evidence in humans - an overview. Food Chem Toxicol 39(12):1125-1134.
19. Boutin M, Dufresne A, Ostiguy C, Lesage J. 2006. Determination of airborne isocyanates generated during the thermal degradation of car paint in body repair shops. Ann Occup Hyg 50(4):385-393.
20. Carroll KB, Secombe CJ, Pepys J. 1976. Asthma due to non-occupational exposure to toluene (tolylene) di-isocyanate. Clip Allergy 6(2):99 104.
21. Collin-Hansen I, Stowe M, Ibrahim K, Redlich C, Liu Y, Youngs F, et al, 2006. Field evaluation of gloves and protective clothing against organic solvents during auto body spray painting [Abstract]. In: American Industrial Hygiene Association Conference 2006, Chicago, IL. Available: http://www.aiha.org/abs06/po119.htm [accessed 19 January 2007].
22. Creely KS, Hughson GW, Cocker J, Jones K. 2006. Assessing isocyanate exposures in polyurethane industry sectors using biological and air monitoring methods. Ann Occup Hyg 50(6):609-621.
23. Cummings KJ, Deubner DC, Day GA, Henneberger PK, Kitt MM, Kent M, et al. Enhanced preventive program at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med; doi: 10.1136/oem.2006 027987 [Online 16 October 2006].
24. Darcey D, Lipscomb HJ, Epling C, Pate W, Cherry LP, Bernstein J. 2002. Clinical findings for residents near a polyurethane foam manufacturing plant. Arch Environ Health 57(3):239-246.
25. De Zotti R, Muran A, Zambon F. 2000. Two cases of paraoccupational asthma due to toluene diisocyanate (TDI). Occup Environ Med 57(12):837-839.
26. Dietemann-Molard A, Kopferschmitt-Kubler MC, Meyer PD, Tomb R, Pauli G. 1991. Allergic asthma due to domestic use of insulating polyurethane foam. Lancet 338(8772):953.
27. Donnelly R, Buick JB, Macmahon J. 2004. Occupational asthma after exposure to plaster casts containing methylene diphenyl diisocyanate. Occup Med (Lond) 54(6):432-434.
28. Erjefält I, Persson CG. 1992. Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy 22(9):854-862.
29. Fent K, Jayaraj K, Gold A, Ball L, Nylander-French L. 2006. Tape-strip sampling for measuring dermal exposure to 1,6-hexamethylene diisocyanate. Scan J Work Environ Health 32(3):225-231.
30. Frick M, Bjorkner B, Hamnerius N, Zimerson E. 2003. Allergic contact dermatitis from dicyclohexylmethane-4,4′-diisocyanate. Contact Dermatitis 48(6):305-309.
31. Frick M, Zimerson E, Karlsson D, Marand A, Skarping G, Isaksson M, et al. 2004 Poor correlation between stated and found concentrations of diphenylmethane-4,4′-diisocyanate (4,4′-MDI) in petrolatum patch-test preparations. Contact Dermatitis 51(2):73-78.
32. Gagne S, Lesage J, Ostiguy C, Van Tra H. 2003. Determination of unreacted 2,4-toluene diisocyanate (2,4TDI) and 2,6-toluene diisocyanate (2,6TDI) in foams at ultratrace level by using HPLC-CIS-MS-MS. Analyst 128(12):1447-1451.
33. Goossens A, Detienne T, Bruze M. 2002. Occupational allergic contact dermatitis caused by isocyanates. Contact Dermatitis 47(5):304-308.
34. Herrick CA, Xu L, McKenzie AN, Tigelaar RE, Bottomly K. 2003. IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen. J Immunol 170(5):2488-2495.
35. Herrick CA, Xu L, Wisnewski AV, Das J, Redlich CA, Bottomly K. 2002. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol 109(5):873-878.
36. Kääriä K, Hirvonen A, Norppa H, Piirila P, Vainio H, Rosenberg C. 2001. Exposure to 4,4′-methylenediphenyl diisocyanate (MDI) during moulding of rigid polyurethane foam: determination of airborne MDI and urinary 4,4′-methylenedianiline (MDA). Analyst 126(4):476-479.
37. Kanerva L, Estlander T, Jolanki R, Keskinen H. 2001. Asthma from diisocyanates is not mediated through a type IV, patch-test-positive mechanism. Contact Dermatitis 44:246-263.
38. Karol MH, Hauth BA, Riley EJ, Magreni CM. 1981. Dermal contact with toluene diisocyanate (TDI) produces respiratory tract hypersensitivity in guinea pigs. Toxicol Appl Pharmacol 58(2):221-230.
39. Kimber I, Dearman RJ. 2002. Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology 181-182:311-315.
40. Krone CA, Ely JT, Klingner T, Rando RJ. 2003. Isocyanates in flexible polyurethane foams. Bull Environ Contam Toxicol 70(2):328-335.
41. Krone CA, Klingner TD. 2005, Isocyanates, polyurethane and childhood asthma. Pediatr Allergy Immunol 16(5):368-379.
42. Lack G, Fox D, Northstone K, Golding J. 2003. Factors associated with the development of peanut allergy in childhood. N Engl J Med 348(11):977-985.
43. Legris M, Lesage J, Trucot A, Bellemare D, Pruchomme H. 1995. Exposure to Isocyanates during the Making of Orthopedic Plaster Costs [in French]. Quebec, Canada:CLSC Chutes-de-la-chaudiere-desjardins.
44. Leibold E, Hoffmann H, Hildebrand B. 1999. MDI: Study of Absorption after Single Dermal and Intradermal Administration in Rats. Manchester, UK:International Isocyanate Institute.
45. Lenaerts-Langanke H. 1992. Isocyanate-induced respiratory disease in coal miners. Zbl Arbeitsmedizin 42:2-25.
46. Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RL, Bernstein IL. 1988. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol 82(1):55-61.
47. Liss DJ, Lutgendorf CS, Daly CM, Stowe MH, Wisnewski AV, Gulati M, et al. 2006. Isocyanate sensitization: a cross sectional study of MDI exposure and effects in the production of polyurethane coated fabrics [Abstract]. Proc Am Thor Soc 2:A816.
48. Littorin M, Welinder H, Skarping G, Dalene M, Skerfving S. 2002. Exposure and nasal inflammation in workers heating polyurethane. Int Arch Occup Environ Health 75(7):468-474.
49. Liu Y, Sparer J, Woskie SR, Cullen MR, Chung JS, Holm CT, et al. 2000. Qualitative assessment of isocyanate skin exposure in auto body shops: a pilot study. Am J Ind Med 37(3):265-274.
50. Maitre A, Berate M, Stoklov M, Savolainen H, Perdrix A. 1996. Human skin penetration study of hexamethylene diisocyanate (HDI) by using biological monitoring to hexamethylene diamine (HDA) [Abstract]. In: International Symposium on Biological Monitoring in Occupational and Environmental Health, 11-13 September 1996, Espoo, Finland.
51. Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. 2005, Occupational asthma. Am J Respir Crit Care Med 172(3):280-305.
52. Moody RP, Maibach HI. 2006. Skin decontamination: importance of the wash-in effect. Food Chem Toxicol 44(11):1783-1788.
53. Morgan CJ, Haworth AE. 2003. Allergic contact dermatitis from 1,6-hexamethylene diisocyanate in a domestic setting. Contact Dermatitis 48(4):224.
54. Munn A. 1965. Hazards of isocyanates. Ann Occup Hyg 8:163-169.
55. Musk AW, Peters JM, Wegman DH. 1988. Isocyanates and respiratory disease: current status. Am J Ind Med 13(3):331-349.
56. Nemery B, Lenaerts L. 1993. Exposure to methylene diphenyl diisocyanate in coal mines. Lancet 341(8840):318.
57. Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. 2005. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 62(5):290-299.
58. NIOSH. 1996. Preventing Asthma and Death from Diisocyanate Exposure. NIOSH Alert 96-111: Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/asthma.html [accessed 16 January 2007].
59. NIOSH. 1998. HETA 98-0011-2801, Woodbridge Corporation, Brodhead, Wisconsin. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/hhe/reports/pdfs/ 1998-0011-2801.pdf [accessed 12 January 2007].
60. NIOSH. 1999. NIOSH Health Hazard Evaluation Report. HETA-99-0196-2860, Future Aviation, Inc., Naples, Florida. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://0-www.cdc.gov.mill1.sjlibrary.org/niosh/hhe/reports/pdfs/ 1999-0196-2860.pdf [accessed 12 January 2007].
61. NIOSH. 2005. NIOSH Pocket Guide to Chemical Hazards. Publication No. 2005-149. Cincinnati, OH:National Institute for Occupational Safety and Health. Available: http://www.cdc.gov/niosh/npg/ [accessed 12 January 2007].
62. Orloff KG, Batts-Osborne D, Kilgus T, Metcalf S, Cooper M. 1998. Antibodies to toluene diisocyanate in an environmentally exposed population. Environ Health Perspect 106:665-666.
63. Peters JM, Murphy RL. 1971. Hazards to health: do it yourself polyurethane foam. Am Rev Respir Dis 104(3):432-433.
64. Petsonk EL, Wang ML, Lewis DM, Siegel PD, Husberg BJ. 2000. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 118(4):1183-1193.
65. Pronk A, Yu F, Vlaanderen J, Tielemans E, Preller L, Bobeldijk I, et al. 2006. Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters. Occup Environ Med 63(9):624-631.
66. Rattray NJ, Botham PA, Hext PM, Woodcock DR, Fielding I, Dearman RJ, et al. 1994. Induction of respiratory hypersensitivity to diphenylmethane-4,4′-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicology 88(1-3):15-30.
67. Redlich CA, Stowe MH, Wisnewski AV, Eisen EA, Karol MH, Lemus R, et al. 2001. Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers. Am J Ind Med 39(6):587-597.
68. Saloga J, Knop J. 2000. Does sensitization through the skin occur? Allergy 55(10):905-909.
69. Scheerens H, Buckley TL, Muis TL, Garssen J, Dormans J, Nijkamp FP, et al. 1999. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med 159(4 pt 1):1074-1080.
70. Sheaarer WT, Fleisher TA. 2003. The immune system. In: Allergy: Principles and Practice (Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, eds), Philadelphia:Mosby, 1-14.
71. Smith Pease CK, White IR, Basketter DA. 2002. Skin as a route of exposure to protein allergens. Clin Exp Dermatol 27(4):296-300.
72. Sommer BG, Sherson DL, Kjoller H, Hansen I, Clausen G, Jepsen JR. 2000. Asthma caused by methylene-diphenyldiisocyanate cast in a nurse [in Danish]. Ugeskr Laeger 162(4):505-506.
73. Stowe M, Liu Y, Wisnewski AV, Sparer J, Holm CT, Cullen M, et al. 2006. Cross-sectional study of auto body workers exposed to diisocyanates: does dermal exposure contribute to sensitization? Proc Am Thor Soc 3:A250.
74. Streicher RP, Kennedy ER, Lorberau CD. 1994. Strategies for the simultaneous collection of vapours and aerosols with emphasis on isocyanate sampling. Analyst 119(1):89-97.
75. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. 2005. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy 35(6):757-766.
76. Tarlo SM, Liss GM. 2005. Prevention of occupational asthma - practical implications for occupational physicians. Occup Med (Lond) 55(8): 588-594.
77. Tarlo SM, Liss GM, Dias C, Banks DE. 1997. Assessment of the relationship between isocyanate exposure levels and occupational asthma. Am J Ind Med 32(5):517-521.
78. Tickle SS, Antonini JM, Rich BA, Roberts JR, Salmon R, DePree K, et al. 2003. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111:1202-1208.
79. Valks R, Conde-Salazar L, Barrantes OL. 2003. Occupational allergic contact urticaria and asthma from diphenylmethane-4,4′-diisocyanatae. Contact Dermatitis 49(3):166-167.
80. Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbelken EK, Nemery B, Hoet PH. 2004. Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol Sci 81(2):310-321.
81. Vanoirbeek JA, Tarkowski M, Vanhooren HM, De Vooght V, Nemery B, Hoet PH. 2006. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J Allergy Clin Immunol 117(5):1090-1097.
82. Vilaplana J, Romaguera C, Grimalt F. 1987. Allergic contact dermatitis from aliphatic isocyanate on spectacle frames. Contact Dermatitis 16(2):113.
83. Vock EH, Lutz WK. 1997. Distribution and DNA adduct formation of radiolabeled methylenediphenyl-4,4′-diisocyanate (MDI) in the rat after topical treatment. Toxicol Lett 92(2):93-100.
84. Welinder H, Nielsen J, Bensryd I, Skerfving S. 1988. IgG antibodies against polyisocyanates in car painters. Clin Allergy 18(1):85-93.
85. Wester RC, Hui X, Landry T, Maibach HI. 1999. In vivo skin decontamination of methylene bisphenyl isocyanate (MDI): soap and water ineffective compared to polypropylene glycol, polyglycol-based cleanser, and corn oil. Toxicol Sci 48(1):1-4.
86. Wilkinson SM, Cartwright PH, Armitage J, English JS. 1991, Allergic contact dermatitis from 1,6-diisocyanatahexane in an anti-pill finish. Contact Dermatitis 25(2):94-96.
87. Wisnewski AV, Lemus R, Karol MH, Redlich CA. 1999. Isocyanate-conjugated human lung epithelial cell proteins: a link between exposure and asthma? J Allergy Clin Immunol 104(2 Pt 1):341-347.
88. Wisnewski AV, Redlich CA, Mapp CE, Bernstein DI. 2006. Polyisocyanates and their prepolymers. In: Asthma in the Workplace (Bernstein LI, Chan-Yeung M, Malo J-L, Bernstein DI, eds). 3rd ed. London:Taylor & Francis, 481-504.
89. Wisnewski AV, Srivastava R, Herick C, Xu L, Lemus R, Cain H, et al. 2000. Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am J Respir Crit Care Med 162(6):2330-2336.
90. Wisnewski AV, Stowe MH, Cartier A, Liu Q, Liu J, Chen L, et al. 2004. Isocyanate vapor-induced antigenicity of human albumin. J Allergy Clin Immunol 113(6):1178-1184.
91. Woskie SR, Sparer J, Gore RJ, Stowe M, Bello D, Liu Y, et al. 2004. Determinants of isocyanate exposures in auto body repair and refinishing shops. Ann Occup Hyg 48(5):393-403.
92. Ye YM, Kim CW, Kim HR, Kim HM, Suh CH, Nahm DH, et al. 2006. Biophysical determinants of toluene diisocyanate antigenicity associated with exposure and asthma. J Allergy Clin Immunol 118(4):885-891.
93. Zammit-Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M. 1983. Asthma caused by diphenylmethane diisocyanate in foundry workers. Clinical, bronchial provocation, and immunologic studies. Am Rev Respir Dis 128(2):226-230.
94. Zhang XD, Fedan JS, Lewis DM, Siegel PD. 2004. Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. J Allergy Clin Immumol 113(2):320-326.